Treatment of Pneumocystis carinii Pneumonitis

Walter T. Hughes

Research output: Contribution to journalEditorial

Abstract

Before a satisfactory treatment became available, the outlook for patients with Pneumocystis carinii pneumonitis was bleak. This illness, unique to the compromised host, proved fatal in 50 per cent of infantile cases during European epidemics and in about 100 per cent of affected children and adults who were immunodeficient because of neoplasia, anticancer therapy, organ transplantation or congenital immune deficiency disorders. In 1958 Idy and Pdy, in Budapest, successfully treated the infection with pentamidine isethionate, a diamidine with antiprotozoal and antifungal activity. They were eventually able to reduce the mortality from infantile P. carinii pneumonitis from 50 per cent to.

Original languageEnglish (US)
Pages (from-to)726-727
Number of pages2
JournalNew England Journal of Medicine
Volume295
Issue number13
DOIs
StatePublished - Sep 23 1976

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Treatment of Pneumocystis carinii Pneumonitis'. Together they form a unique fingerprint.

  • Cite this